Background Following advances in treatment for hepatitis C (HCV), optimizing linkage to
care and adherence to treatment of people who inject drugs became of pivotal importance …

Abstract The World Health Organisation has established a goal of eliminating the hepatitis C
virus (HCV) as a public health threat by 2030. Considerable effort is being directed towards …

Background Non‐alcoholic fatty liver disease (NAFLD) is a highly prevalent condition that
requires a comprehensive and coordinated response across sectors and disciplines. Aims In …

Abstract Background and Aims People who inject drugs (PWID) and other marginalized
populations with high hepatitis C virus (HCV) infection rates represent a unique challenge …

METHODS All participants were offered PoC education and HCV screening. HCV-positive
participants were randomised to standard care (controls) or direct access, which provided a …

Background and aims Hepatitis C virus (HCV) treatment is essential for eliminating HCV in
people who inject drugs (PWID), but has limited coverage in resource‐limited settings. We …

Hepatitis C (HCV) infection among people who inject drugs (PWID) is a major public health
concern. We examined correlates of HCV antibody (anti‐HCV) seropositivity and …

Objectives People who inject drugs (PWID) constitute a population group with a high
hepatitis C virus (HCV) burden. With the objectives of assessing the HCV prevalence in …

Introduction and objectives The majority of studies regarding hepatitis C virus (HCV)
prevention, screening, and treatment have been conducted in urban populations, and it is …

Abstract Objective The World Health Organisation aims to eliminate Hepatitis C (HCV) by
2030. To achieve this, targeted testing needs to be widely available. Studies have …